Solve ME/CFS Initiative

Making ME/CFS, Long Covid & associated conditions widely understood, diagnosable, & treatable. #SolveME #MECFS #LongCovid Donate @

[Solve ME/CFS Initiative @PlzSolveCFS]

Join us for a webinar with panelists from DecodeME and ActionForME to discuss their Catalyst Award-winning study on Sequence ME and Long Covid and how it could impact the search for biomarkers and subtypes.
https://t.co/iblKQbvoqX
#MEAwarenessHour

[Billy Hanlon @bhanlon15]

WBUR: 'The scope of long COVID is bigger than we think, Mass. researchers say'

“I think Long Covid is a serious national and global problem that demands attention from governments and international bodies" - Dr. Ziyad Al-Aly

https://t.co/qzQrTDDsB8

[ResearchAmerica @ResearchAmerica]

Do you know an ✨ exceptional ✨ research advocate?

Nominations are now open for Research!America's 2027 Advocacy Awards! 🏆
Honor outstanding advocates for medical, health, and scientific research by submitting your nominations today.

👉 Explore the list of available awards and learn more about nominations:
https://t.co/zQZel871lu

📆 All nominations must be submitted no later than Friday, July 17, 2026.

#RAAwards #Research #Advocacy #HealthResearch

[Solve ME/CFS Initiative @PlzSolveCFS]

With your support, Solve can fund studies that bridge the gap between research & clinical trials, and help scientists move closer to testing new therapies in people with #MECFS and #LongCovid.

All gifts made through June 30 will be DOUBLED up to $200,000!
https://t.co/jBuQr0ziGh

[ME/CFS Science @mecfsskeptic]

1) Action for ME is launching the PRIME ME/CFS Research Involvement Hub.

It aims to create the world’s first network of at least 100 people with lived experience of ME, supported and trained in Patient and Public Involvement (PPI) to work alongside researchers.

[Solve ME/CFS Initiative @PlzSolveCFS]

With your help, we can turn momentum into real breakthroughs. Your gift to Solve today supports studies that can translate discoveries into treatments.

And now, all gifts made through June 30th will be matched up to $200,000!

https://t.co/jBuQr0ziGh

[Solve ME/CFS Initiative @PlzSolveCFS]

Congratulations to @BioVie_Pharma on completing enrollment for this important trial. We're so pleased to have assisted with recruitment and look forward to sharing insights from the data collected with the community!

[BioVie Inc @BioVie_Pharma]

Enrollment is complete in our Phase 2 ADDRESS-LC clinical trial evaluating bezisterim for the treatment of neurological symptoms of Long COVID, with topline data expected in late summer 2026.
Learn more: https://t.co/jwvyyefMB6 $BIVI

[Amy Rochlin @amyrochlin]

RESEARCH ROLLOUT!

Announcing @CODA_research’s Multisystem Research Model for Complex Disorders, including Long COVID, ME/CFS, POTS/dysautonomia, EDS/HSD, MCAS, chronic pain, IBS, and related conditions.

After an extensive review of the neuroimmune research landscape, CODA presents a multisystem research model built around 5 interconnected scientific domains that together represent some of the strongest emerging areas of investigation in complex chronic disease:

• Neuroimmune Signaling
• Immune Network Dysregulation
• Viral & Microbial Persistence
• CSF, Glymphatics, Cerebral & Venous Blood Flow
• Structural Mechanics & Instability

Together, these domains form the foundation of CODA’s growing neuroimmune research portfolio.

CODA’s portfolio approach connects patients to the science that may matter most to them while advancing an integrated understanding of complex neuroimmune disease.

🧵
Read my full blog on CODA’s research & studies:
https://t.co/cYM0jdkvHI

[Solve ME/CFS Initiative @PlzSolveCFS]

Wed. 6/3 at 10 am PDT / 1 pm EDT, join @KantorKantor & @4Workwell for a free webinar: "Proving Disabling Post-Exertional Malaise and Fatigue: Understanding Disability Benefits and the Two-Day CPET."

https://t.co/TNsDitzHJL
#PEM #DisabilityBenefits

[Solve ME/CFS Initiative @PlzSolveCFS]

Join us for a webinar with panelists from DecodeME and ActionForME to discuss their Catalyst Award-winning study on Sequence ME and Long Covid and how it could impact the search for biomarkers and subtypes.
https://t.co/iblKQbvoqX
#MEAwarenessHour

[Solve ME/CFS Initiative @PlzSolveCFS]

Register for our Sept. 8 webinar with Dr. Jay H. Chung (NIH) discussing his Solve ME/CFS Catalyst Award-winning study of a potential safe and accessible treatment for #MECFS.
https://t.co/juY29GEfu7

[Solve ME/CFS Initiative @PlzSolveCFS]

🚨 BIG NEWS: Our Matching Challenge has been extended to June 30—and increased to $200,000! 🎉 Your gift today will go TWICE as far to support #MECFS + #LongCovid research and accelerate real breakthroughs for millions.
Donate now: https://t.co/jBuQr0ziGh

[Solve ME/CFS Initiative @PlzSolveCFS]

Our friends at @BrainInflCollab are hosting @CenterRes & Anvita Guda for a webinar on #MECFS & brain inflammation, cognitive dysfunction, and patient-centered research on 5/21 @ 2:00 PM CT/3:00 PM ET. Sign up: https://t.co/hUJVaGLeGH

[Solve ME/CFS Initiative @PlzSolveCFS]

Check out this new piece in @thesicktimes highlighting the work of Solve #MECFS Catalyst Award & Ramsay Grant winner @C_Scheibenbogen ⬇️

[The Sick Times @thesicktimes]

A “unifying” hypothesis of the mechanisms, triggers, and risk factors for myalgic encephalomyelitis (ME), is gaining support. Further evaluation and development of a potential drug depend on funding. https://t.co/b7d7zNy9I1

[Solve ME/CFS Initiative @PlzSolveCFS]

During Advocacy Week 2026, we asked Congress to keep #MECFS as an eligible topic area in the Congressionally Directed Medical Research Program (#CDMRP). Read the case we made for it here:
https://t.co/kp39yF8EuS

[Billy Hanlon @bhanlon15]

Wanted to pin for June 2, hosted by Minnesota Dept. of Health: 'Statewide Conversation on Post-Viral Chronic Illness A Day of Learning, Connection & Action'

When: 6/2/26, 9A-2P CT on Zoom

Though the event is MN‑focused, it is open to all

Register here: https://t.co/Dz42KKFJVF

[Solve ME/CFS Initiative @PlzSolveCFS]

Check out the @LAWeekly feature on Solve CEO Emily Taylor. The piece highlights how caregiving for her mother informs Emily's commitment to accelerating research breakthroughs and the creation of our ME/CFS Catalyst Awards Program.

https://t.co/40jWH5MVRk

[Cort Johnson @CortJohnson]

A Novel Immunomodulatory Strategy for ME/CFS + A Paradox Resolved? #MECFS https://t.co/P8ssuZW1M4

[The Sick Times @thesicktimes]

This week's #LongCOVID research updates: https://t.co/us3R4c1OqZ

[Solve ME/CFS Initiative @PlzSolveCFS]

Register for our Sept. 8 webinar with Dr. Jay H. Chung (NIH) discussing his Solve ME/CFS Catalyst Award-winning study of a potential safe and accessible treatment for #MECFS.
https://t.co/juY29GEfu7
#MEAwarenessHour